![A semaglutide injection pen](https://www.uc.edu/news/articles/2024/02/n21229763/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1708962710206.jpg)
CNN: The questions eating disorder experts have about weight loss medications
The University of Cincinnati's Susan McElroy, MD, spoke with CNN about the impact weight loss medications like semaglutide have on people with eating disorders. McElroy's research focuses on eating disorders, bipolar disorder and the cooccurrence of psychiatric illness with obesity.
Semaglutide, sold under brand names like Ozempic and Wegovy, are a kind of drug called glucagon-like peptide-1 receptor agonists or GLP-1 agonists. While originally prescribed for diabetes, semaglutide is becoming more and more popular for weight loss.
McElroy said there is little research on the connection between eating disorders and weight loss medications.
“I view eating disorders as the last frontier in psychiatry,” said McElroy, the Linda and Harry Fath endowed professor in the Department of Psychiatry & Behavioral Neuroscience in UC’s College of Medicine and chief research officer at the Lindner Center of HOPE. “The eating disorder field is hard because we’re just ignored.”
In general, medications that cause weight loss have a good chance to also reduce binge eating, McElroy said, but there currently isn't enough research into how to treat disorders like binge eating disorder with these medications.
“We desperately need more compounds to treat people with eating disorders,” McElroy said.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
President picks exceptional talent
April 28, 2021
The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
Grad students earn president's highest honor
April 28, 2021
The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
GIVEHOPE and BSI Engineering Celebrate Ten Years of Driving Research
August 3, 2021
Years after two personal losses from pancreatic cancer, Cincinnati-based nonprofit GIVEHOPE and consulting firm BSI Engineering are celebrating a philanthropic partnership that has funded 13 pilot research projects at the University of Cincinnati Cancer Center.
Finding community and building a future
July 9, 2021
As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”
New York Times: Flint Weighs Scope of Harm to Children Caused by Lead in Water
February 1, 2016
Kim Dietrich, a professor of environmental health at UC's College of Medicine, is quoted in this story on the medical problems that could develop among the thousands of young children exposed to lead-contaminated water in Flint, Mich.
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
February 18, 2016
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.
UC Receives $1.9 Million to Study Pain
February 15, 2016
Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.
MD Magazine: Generic Drug Equally Effective in Epilespy
February 22, 2016
Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.
UC to Host Regional Conference for Latino Medical Student Association
February 10, 2016
The University of Cincinnati chapter of the Latino Medical Student Association (LMSA) will host a Midwest regional conference Feb. 26-28, 2016, at the College of Medicine.
Heart Disease Still Top Killer of American Women and Men, Symptoms Differ
February 1, 2016
Women tend to get palpitations, shortness of breath and "sharp" chest pain when suffering heart attacks, explains Stephanie Dunlap, DO, in the UC College of Medicine.